RIKEN GENESIS
Specializes in promotion of personalized medicine based on contract analysis of next-generation sequencing and exomes.
Launch date
Employees
Market cap
-
Enterprise valuation
€106—160m (Dealroom.co estimates Jun 2014.)
Tokyo Japan (HQ)